跳至主要内容
临床试验/NCT05943002
NCT05943002招募中不适用

Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia

German Center for Neurodegenerative Diseases (DZNE)6 个研究点 分布在 3 个国家目标入组 200 人开始时间: 2023年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
6
主要终点
Health-related quality of life

研究概览

简要总结

The PROFA study is an international, multi-centric observational and validation study to assess the patient-reported, psychosocial and economic outcomes of patients with Friedreich Ataxia (FA). Eligible patients will be recruited from six study centers in Germany, Austria and France. Patients will complete a baseline assessment via face-to-face interviews at the study centers and multiple momentary follow-up assessments via a mobile-health app at home daily to monthly for six months. Study results will gain essential and in-depth insights into the daily life of patients with FA.

详细描述

There is a lack of knowledge about the patient-reported, psychosocial, and economic impact of Friedreich's Ataxia (FA). The few previous studies were based on small sample sizes and annual cross-sectional data, limiting the generalizability of the results.

Therefore, the PROFA study aims

  1. to assess the acceptability, feasibility, and usability of a mobile-health app for the collection of longitudinal real-time data,
  2. to determine healthcare costs from a societal perspective that includes informal care productivity losses, to assess associated factors and to analyze the impact of evidence-based treatment on costs,
  3. to validate measures of health-related quality of life (HRQoL), to assess patients' HRQoL and its fluctuation over time and identify associated factors,
  4. to develop, validate and evaluate a new measure of hearing and speech disabilities' impact on patients' psychosocial health, and
  5. to evaluate interaction effects between HRQoL, psychosocial health and economic outcomes in patients with FA.

Thus, the PROFA study will gain a comprehensive understanding of the individual, societal, and economic burden of FA, identifying determinants of health and social life and efficient use of healthcare resources. This is crucial to improve the treatment, care, and everyday life of FA patients and their families.

This validation and observational study will recruit patients from six study centers (Germany, France, and Austria). The data assessment will be based on (i) a baseline assessment via interviews at the study centers and (ii) a subsequent remote momentary data assessment via a mobile-health app on a daily to monthly basis for six months, covering assessments of ataxia severity, HRQoL, psychosocial health, speech and hearing disabilities, health services utilization, and specific health events. Descriptive and multivariate statistics will be used to describe the impact of FA on the patient-reported HRQoL, psychosocial health and economic outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • FA confirmed by molecular genetic testing
  • Ataxia severity of ≤30 points according to the Scale of the Assessment and Rating of Ataxia (SARA)
  • Access to a smartphone or tablet and able to operate the device
  • Older than 12 years

排除标准

  • Lack of ability to give consent
  • Ataxia severity >30 according to the Scale of the Assessment and Rating of Ataxia (SARA)

结局指标

主要结局

Health-related quality of life

时间窗: Month 6

Health-related quality of life assessed by the "Patient Reported Outcome Measures for Ataxia" Short-Form (PROM-ATAX), with a score range between 0 to 40 with higher scores indicating lower health-related quality of life

Psychosocial health due to communication handicaps caused by speech and hearing disabilities

时间窗: Month 6

Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties)

Fluctuation of health-related quality of life

时间窗: Day one, two and three in months 6

Change in health-related quality of life measured by the 5-level EQ-5D version (EQ-5D-5L) with a score range between 0 and 1 (higher values indicate higher health-related quality of life)

Total societal costs

时间窗: Six months

Aggregated healthcare costs of utilized healthcare services, informal care and productivity losses

Usability of the mobile-health app as a remote monitoring momentary data assessment tool

时间窗: Six months

Completeness of data

Acceptability of the mobile-health app as a remote monitoring momentary data assessment tool

时间窗: Month 6

Acceptability is assessed by a self-developed questionnaire (asking patients to rate the app based on user experience)

Health-related quality of life

时间窗: Month 1

Health-related quality of life assessed by the "Patient Reported Outcome Measures for Ataxia" Short-Form (PROM-ATAX), with a score range between 0 to 40 with higher scores indicating lower health-related quality of life

Health-related quality of life

时间窗: Month 3

Health-related quality of life assessed by the "Patient Reported Outcome Measures for Ataxia" Short-Form (PROM-ATAX), with a score range between 0 to 40 with higher scores indicating lower health-related quality of life

Health-related quality of life

时间窗: Month 5

Health-related quality of life assessed by the "Patient Reported Outcome Measures for Ataxia" Short-Form (PROM-ATAX), with a score range between 0 to 40 with higher scores indicating lower health-related quality of life

Psychosocial health due to communication handicaps caused by speech and hearing disabilities

时间窗: Month 1

Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties)

Psychosocial health due to communication handicaps caused by speech and hearing disabilities

时间窗: Month 2

Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties)

Psychosocial health due to communication handicaps caused by speech and hearing disabilities

时间窗: Month 3

Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties)

Psychosocial health due to communication handicaps caused by speech and hearing disabilities

时间窗: Month 4

Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties)

Psychosocial health due to communication handicaps caused by speech and hearing disabilities

时间窗: Month 5

Psychosocial impact of hearing and speech disabilities assessed by the "Scale for the psychosocial impact of hearing and speech disabilities in Friedreich Ataxia" (COM-ATAX) with a score range between 0 to 68 (higher scores indicate more difficulties)

Fluctuation of health-related quality of life

时间窗: Day one, two and three in months 1

Change in health-related quality of life measured by the 5-level EQ-5D version (EQ-5D-5L) with a score range between 0 and 1 (higher values indicate higher health-related quality of life)

Fluctuation of health-related quality of life

时间窗: Day one, two and three in months 3

Change in health-related quality of life measured by the 5-level EQ-5D version (EQ-5D-5L) with a score range between 0 and 1 (higher values indicate higher health-related quality of life)

Fluctuation of health-related quality of life

时间窗: Day one, two and three in months 5

Change in health-related quality of life measured by the 5-level EQ-5D version (EQ-5D-5L) with a score range between 0 and 1 (higher values indicate higher health-related quality of life)

次要结局

未报告次要终点

研究者

发起方
German Center for Neurodegenerative Diseases (DZNE)
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验